EX-10.5 4 btmd-ex10_5.htm EX-10.5 EX-10.5

 

展览10.5

执行版本

信贷协议及豁免的第一修正案

这份关于信用协议及豁免的首次修正,日期为2024年4月26日,由BIOTE医疗有限责任公司(一家德克萨斯州有限责任公司)、以及BIOTE控股有限责任公司(一家特拉华州有限责任公司)等签署。协议,日期为2024年4月26日,由 BIOTE 医疗有限责任公司(一家德克萨斯州有限责任公司)及 BIOTE 控股有限责任公司(一家特拉华州有限责任公司)等签署入。第一修正案生效日期,由 BIOTE 医疗有限责任公司(一家德克萨斯州有限责任公司)及 BIOTE 控股有限责任公司(一家特拉华州有限责任公司)等签署。借款人,一家特拉华州有限责任公司Holdings),其他担保方,贷款方以及作为行政代理的Truist银行(“行政代理人”).

鉴于,计划第17.2节保留了Celldex Therapeutics,Inc.(以下称为“公司”)董事会(以下称为“董事会”)修订计划的权利;和

鉴于,借款人、控股公司、其他担保方、贷款人和管理代理已经签订了某项信贷协议,日期为2022年5月26日(被修订、重订、被修订和重订、补充、增加、延长、再融资、续约、更换和/或以书面形式不时修改的,该“授信协议 (Credit Agreement)”);

鉴于,借款方未能遵守信用协议第7.5节中规定的条款,同意根据多诺维兹和解协议(在本协议的定义中)为购买母公司和控股公司股票进行受限支付,并因此,信用协议已发生违约事件(称为“指定事件 违约”);

鉴于借款人请求放弃特定违约事件并修改信贷协议如下,在本协议规定的条款和条件下;

鉴于,放款人(由构成必要放款人和必要循环放款人的放款人行为)已同意放弃特定违约事件,并根据本文所载条款和条件对信贷协议进行请求的修订。

现在,鉴于本协议所载内容并为其他有价值的考虑,茲特确认各方已收到并认可足额,特此各方一致同意如下:

协议

1.
介绍性段落和背景资料; 定义上述介绍性段落和背景资料(包括其中定义的任何条款)已被引用并作为本协议的一部分纳入,如同完整地载于本协议正文。本协议中使用但未在此处另有定义的大写词汇,应当具有在信贷协议中所赋予的相应含义(本协议对该协议进行了修订,或在本协议生效之前立即生效的情况下,根据情境可能需要的效力)。
2.
豁免特定违约事件;释放。
(a)
根据信贷协议第11.2节(放弃; 修订),在满足本协议中列明的所有条款和条件的前提下,债权人(由构成强制债权人和强制循环贷款人的债权人行使)特此豁免指定违约事件,并同意指定违约事件不再继续适用于信贷协议和其他贷款文件的目的。除了本 。每个认购单位应支付的购买价格应等于每个企业单位在 第2(a)章 中的价格。中明确豁免的内容外,本 。每个认购单位应支付的购买价格应等于每个企业单位在 第2(a)章 中的价格。 中的任何内容均不得被解释为对信贷协议或任何其他贷款文件的修改,也不得被视为放弃(i)任何权利或

 


 

本处所述的豁免不排除行使信贷协议或任何其他贷款文件下管理员代理、任何放款人、开证银行或摊融放款人可能具有的任何救济权或适用法律下的义务,也不排除任何贷款方完全遵守信贷协议或任何其他贷款文件中包含的任何职责、条款、条件、义务或契约。本处所述的豁免 。每个认购单位应支付的购买价格应等于每个企业单位在 第2(a)章 中的价格。 仅为一次性豁免,仅在涉及指明违约事件时有效,不得要求管理员代理、任何放款人、开证银行或摊融放款人豁免任何其他现有或今后产生的违约或违约事件。本协议规定的条款和协议不得建立管理员代理、任何放款人、开证银行、摊融放款人和/或任何贷款方之间的惯例或债务处理方式。
(b)
考虑到贷款人愿意签订本协议,各贷款方特此解除行政代理人、每家贷款机构、发卡银行和Swingline贷款人(各为”指定当事方” 总的来说,”特定当事方”),以及每个特定方的每位前任、继任者、受让人、高级职员、经理、董事、员工、代理人、律师、代表和关联公司(以下简称 “上述所有人员,以及特定各方,统称为”贷款人集团”)来自任何和所有索赔、反诉、要求、损害赔偿、债务、诉讼、责任、诉讼和任何性质的诉讼原因,均限于与贷款文件或在第一修正案生效日当天或之前由贷款文件引起或与贷款文件相关的任何谈判、活动、事件或情况,无论是法律还是权益,无论是已知还是未知,无论责任是直接还是间接的流动资金,已清算或未清算,无论是绝对的还是偶然的,可预见的还是不可预见的,以及无论此前是否断言,该贷款方可能对贷款人集团的任何成员持有或声称拥有何种说法。
3.
信用协议修订事项根据信贷协议第11.2节的规定,经构成必要贷款人和必要循环贷款人的贷款人行为,信贷协议如下进行修改:放弃; 修订根据信贷协议第11.2节的规定,经构成必要贷款人和必要循环贷款人的贷款人行为,信贷协议如下进行修改:
(a)
“贷款协议第1.1节中""Consolidated Fixed Charges""的定义中的第(b)款被完全修改如下:“贷款协议第1.1节中""Consolidated Fixed Charges""的定义中的第(b)款被完全修改如下:“贷款协议第1.1节中""Consolidated Fixed Charges""的定义中的第(b)款被完全修改如下:定义“贷款协议第1.1节中""Consolidated Fixed Charges""的定义中的第(b)款被完全修改如下:
(b)
在此期间就《合并总债务》支付的正常计划本金还款(排除义务性预付款项)进行支付(为避免疑问,不包括(i)根据 第2.12节。“(ii)资不抵债不导致承诺减少的循环贷款支付(包括但不限于循环贷款),(iii)控股及其子公司之间的公司间债务支付,以及(iv)根据Donovitz解决协议允许的向母公司回购股本的支付)支付情形。' '第7.5(d)条')以及在该期间由控股及其子公司以现金支付的资本租赁债务,每种情况都以最近结束的四(4)个财务季度的合并基础进行衡量。四(4)个最近结束的财政季度期间,按合并基础衡量控股及其子公司支付的《资本租赁租约》款项。
(b)
信贷协议的1.1节(定义)被修改以按照适当的字母顺序插入以下定义的术语:

Donovitz和解协议”意指2024年4月23日生效的某项和解协议,涉及 inter alios,母公司和Gary S. Donovitz博士。

(c)
In Section 1.1 (Definitions) of the Credit Agreement, the definition of “Material Agreements” is hereby amended in its entirety to read as follows:

2


 

Material Agreements” shall mean (i) all agreements, indentures or notes governing the terms of any Material Indebtedness, (ii) the Donovitz Settlement Agreement, and (iii) all other agreements, documents, contracts, indentures and instruments pursuant to which (A) any Loan

Party or any of its Subsidiaries are obligated to make payments in any twelve month period in excess of the Threshold Amount, (B) any Loan Party or any of its Subsidiaries expects to receive revenue in any twelve month period in excess of the Threshold Amount and (C) a default, breach or termination thereof could reasonably be expected to result in a Material Adverse Effect.

(d)
Clause (d) in Section 7.5 (Restricted Payments) of the Credit Agreement is hereby amended in its entirety to read as follows:

(d) payments for repurchases of Capital Stock in the Parent pursuant to the Donovitz Settlement Agreement in amounts equal to (i) $32,162,261.67 on the date that is three business days after the effective date of the Donovitz Settlement Agreement (such date, the “Settlement Agreement Closing Date”), (ii) $15,081,130.83 on or before the 12-month anniversary of the Settlement Agreement Closing Date, (iii) $19,081,130.83 on or before the 24-month anniversary of the Settlement Agreement Closing Date, and (iv) $10,540,565.42 on or before the 36-month anniversary of the Settlement Agreement Closing Date;

4.
Effectiveness; Condition Precedent. This Agreement shall become effective as of the First Amendment Effective Date upon receipt by the Administrative Agent of a counterpart of this Agreement duly executed by each of the Administrative Agent, Lenders constituting Required Lenders and Required Revolving Lenders, the Borrower, Holdings, and the other Guarantors.
5.
Miscellaneous.
(a)
This Agreement shall be deemed to be, and is, a Loan Document.
(b)
Effective as of the First Amendment Effective Date, all references to the Credit Agreement in each of the Loan Documents shall hereafter mean the Credit Agreement as amended by this Agreement.
(c)
Except as expressly modified by this Agreement, the Credit Agreement, the Loan Documents, and the obligations of each Loan Party thereunder and under the other Loan Documents are hereby ratified and confirmed and shall continue and remain in full force and effect according to their respective terms.
(d)
Each of the Loan Parties: (i) acknowledges and consents to all of the terms and conditions of this Agreement; (ii) agrees that this Agreement, and all documents executed in connection herewith, do not operate to reduce or discharge any of its obligations under the Credit Agreement or the other Loan Documents, or any certificates, documents, agreements and/or instruments executed in connection herewith or therewith; (iii) affirms all of its respective obligations under the Loan Documents; (iv) agrees that this Agreement shall in no manner impair, or otherwise adversely affect, any of the Liens granted in, or pursuant to, any of the Loan Documents; and (v) affirms that each of the Liens granted in, or pursuant to, any of the Loan Documents is valid and subsisting.
(e)
Each of the Loan Parties hereby represents and warrants to the Administrative Agent and each of the Lenders as follows:
(i)
such Loan Party has taken all necessary action to authorize the execution, delivery and performance of this Agreement;
(ii)
this Agreement has been duly executed and delivered by such Loan Party and constitutes such Loan Party’s legal, valid and binding obligations, enforceable in accordance with

3


 

its terms;
(iii)
no consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by any Loan Party of this Agreement;
(iv)
after giving effect to this Agreement, all representations and warranties of each Loan Party set forth in the Loan Documents are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) as of such earlier date; and
(v)
after giving effect to this Agreement, no Default or Event of Default exists.
(f)
This Agreement may be executed by one (1) or more of the parties to this Agreement on any number of separate counterparts (including by telecopy), and all of said counterparts, taken together, shall be deemed to constitute one (1) and the same instrument. Delivery of an executed counterpart of a signature page of this Agreement by facsimile transmission or by any other electronic imaging means (including in “.pdf” form), shall be effective as delivery of a manually executed counterpart of this Agreement.
(g)
THIS AGREEMENT, AND ANY CLAIMS, CONTROVERSIES, DISPUTES OR CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF, OR RELATING TO THIS AGREEMENT, AND/OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE CONSTRUED IN ACCORDANCE WITH, AND BE GOVERNED BY, THE LAWS (WITHOUT GIVING EFFECT TO THE CONFLICT OF LAW PRINCIPLES THEREOF) OF THE STATE OF NEW YORK.
6.
Reaffirmation of Obligations. Each of the Loan Parties: (a) acknowledges and consents to all of the terms and conditions of this Agreement; (b) affirms all of its obligations under the Loan Documents (as amended by this Agreement); and (c) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not operate to reduce or discharge such Loan Party’s obligations under the Loan Documents (except to the extent that such obligations are expressly modified pursuant to this Agreement).
7.
Reaffirmation of Security Interests. Each of the Loan Parties: (a) affirms that each of the Liens granted in, or pursuant to, any of the Loan Documents is valid and subsisting; and (b) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not, in any manner, impair, or otherwise adversely affect, any of the Liens granted in, or pursuant to, any of the Loan Documents.
8.
No Other Changes. Except as expressly modified hereby, all of the terms and provisions of the Loan Documents shall remain in full force and effect.

 

[Remainder of Page Intentionally Left Blank; Signature Pages Follow]

4


 

IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered by their respective authorized officers as of the day and year first above written.

 

BORROWER:

BIOTE MEDICAL, LLC,

a Texas limited liability company

 

 

 

 

 

 

By:

 

BIOTE HOLDINGS, LLC, its Sole Member

 

By:

 

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

GUARANTORS:

BIOTE HOLDINGS, LLC,

a Delaware limited liability company

 

 

 

 

 

 

 

 

 

 

By:

 

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

BIOTE IP, LLC,

a Nevada limited liability company

 

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

Signature Page to First Amendment to Credit Agreement and Waiver (BioTE Medical, LLC)

 


 

 

ADMINISTRATIVE AGENT:

TRUIST BANK,

as the Administrative Agent

 

 

 

 

 

 

By:

 

/s/Troy R. Weaver

 

Name:

 

Troy R. Weaver

 

Title:

 

Managing Director

 

 


 

 

LENDERS:

TRUIST BANK,

 

as a Lender, the Issuing Bank and the Swingline Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Troy R. Weaver

 

Name

 

Troy R. Weaver

 

Title:

 

Managing Director

 

 

 

 

 

 

 

 

 

 


 

 

 

BANK OF AMERICA, N.A.,

 

as a Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Alexander L. Rody

 

Name

 

Alexander L. Rody

 

Title:

 

Senior Vice President

 

 

 

 

 

 

 

 

 

 

 


 

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION,

 

as a Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Matthew Beltman

 

Name

 

Matthew Beltman

 

Title:

 

Director